| GA20348-1mg |
|
2022976-04-9 |
|
0 |
C184H281N49O61S |
|
|
|
| GA20348-005mg |
|
2022976-04-9 |
|
0 |
C184H281N49O61S |
|
|
|
| GA20348-001mg |
|
2022976-04-9 |
|
0 |
C184H281N49O61S |
|
|
|
| GA20347-25mg |
|
82602-88-8 |
(β-Asp⁵)-Delta-Sleep Inducing Peptide
|
0 |
C35H48N10O15 |
|
|
|
| GA20347-5mg |
|
82602-88-8 |
(β-Asp⁵)-Delta-Sleep Inducing Peptide
|
0 |
C35H48N10O15 |
|
|
|
| GA20346-1mg |
|
1926163-85-0 |
(β-Asp³)-VIP (human, mouse, rat)
|
0 |
C147H238N44O42S |
|
|
|
| GA20346-005mg |
|
1926163-85-0 |
(β-Asp³)-VIP (human, mouse, rat)
|
0 |
C147H238N44O42S |
|
|
|
| GA20345-1mg |
|
2022972-68-3 |
|
0 |
C184H281N49O61S |
|
|
|
| GA20345-005mg |
|
2022972-68-3 |
|
0 |
C184H281N49O61S |
|
|
|
| GA20345-001mg |
|
2022972-68-3 |
|
0 |
C184H281N49O61S |
|
|
|
| GA20344-25mg |
|
127633-71-0 |
(β-Ala⁸)-Neurokinin A (4-10)
|
0 |
C35H56N8O10S |
|
|
|
| GA20344-5mg |
|
127633-71-0 |
(β-Ala⁸)-Neurokinin A (4-10)
|
0 |
C35H56N8O10S |
|
|
|
| GA20343-25mg |
|
223538-61-2 |
(Z-Asp-Glu-Val-Asp)₂-Rhodamine 110
|
0 |
C72H78N10O27 |
|
|
|
| GA20343-5mg |
|
223538-61-2 |
(Z-Asp-Glu-Val-Asp)₂-Rhodamine 110
|
0 |
C72H78N10O27 |
|
|
|
| GA20343-1mg |
|
223538-61-2 |
(Z-Asp-Glu-Val-Asp)₂-Rhodamine 110
|
0 |
C72H78N10O27 |
|
|
|
| GA20342-100mg |
|
16376-83-3 |
|
0 |
C45H64N12O9 |
|
|
|
| GA20342-25mg |
|
16376-83-3 |
|
0 |
C45H64N12O9 |
|
|
|
| GA20341-1mg |
|
1678415-83-2 |
(Val³⁴)-Amyloid β-Protein (1-40)
|
0 |
C193H293N53O58S |
|
|
|
| GA20341-005mg |
|
1678415-83-2 |
(Val³⁴)-Amyloid β-Protein (1-40)
|
0 |
C193H293N53O58S |
|
|
|
| GA20340-25mg |
|
727727-66-4 |
(Val²)-Amyloid β-Protein (1-6)
|
0 |
C35H51N11O11 |
|
|
|
